Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Surgery Method
1.1.3. Application
1.1.4. End Use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Surgery method outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Corneal Implants Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Corneal Implants Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Corneal Implants: Type Estimates & Trend Analysis
4.1. Corneal Implants Market: Key Takeaways
4.2. Corneal Implants Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Human Cornea
4.3.1. Human Cornea market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Synthetic
4.4.1. Synthetic market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Corneal Implants Market: Surgery Method Estimates & Trend Analysis
5.1. Corneal Implants Market: Key Takeaways
5.2. Corneal Implants Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Penetrating Keratoplasty
5.3.1. Penetrating keratoplasty market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Endothelial Keratoplasty
5.4.1. Endothelial keratoplasty market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Corneal Implants Market: Application Estimates & Trend Analysis
6.1. Corneal Implants Market: Key Takeaways
6.2. Corneal Implants Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Keratoconus
6.3.1. Keratoconus market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Fuchs Dystrophy
6.4.1. Fuchs dystrophy market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Infectious Keratitis
6.5.1. Infectious keratitis market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Corneal Ulcers
6.6.1. Corneal ulcers market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Corneal Implants Market: End-use Estimates & Trend Analysis
7.1. Corneal Implants Market: Key Takeaways
7.2. Corneal Implants Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Ophthalmic Centers
7.4.1. Ophthalmic center market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Ambulatory Surgical Centers
7.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Corneal Implants Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Corneal Implants Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Florida Lions Eye Bank
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Alcon Inc.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Aurolab
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. CorneaGen
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. AJL Ophthalmic S.A.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. DIOPTEX
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Massachusetts Eye and Ear
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. San Diego Eye Bank
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. KeraMed, Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Presbia PLC
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer